Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
1.
Cell Host Microbe ; 28(2): 298-305.e3, 2020 08 12.
Article in English | MEDLINE | ID: mdl-32697939

ABSTRACT

The urinary microbiome is a relatively unexplored niche that varies with gender. Urinary microbes, especially in aging populations, are associated with morbidity. We present a large-scale study exploring factors defining urinary microbiome composition in community-dwelling older adult women without clinically active infection. Using 1,600 twins, we estimate the contribution of genetic and environmental factors to microbiome variation. The urinary microbiome is distinct from nearby sites and unrelated to stool microbiome with more Actinobacteria, Fusobacteria and Proteobacteria, but fewer Bacteroidetes, Firmicutes and Verrumicrobia. A quarter of variants had heritability estimates greater than 10% with most heritable microbes having potential clinical relevance, including Escherichia-Shigella linked to urinary tract infections. Age, menopausal status, prior UTI, and host genetics were top factors defining the urobiome with increased microbial diversity tending to associate with older age. These findings highlight the distinct composition of the urinary microbiome and significant contributions of host genetics.


Subject(s)
Aging , Bacteria/classification , Bacteria/isolation & purification , Microbiota/physiology , Urinary Tract/microbiology , Urine/microbiology , Age Factors , Aged , Aged, 80 and over , Bacteria/genetics , Female , Humans , Microbiota/genetics , Middle Aged , RNA, Ribosomal, 16S/genetics , Sex Factors
2.
Urologe A ; 49(11): 1385-9, 2010 Nov.
Article in German | MEDLINE | ID: mdl-20844860

ABSTRACT

A 22-year-old patient attended the urological office with unclear bladder symptoms, haemorrhoids and haematuria. Splenomegaly was detected by ultrasound together with the suspicion of a bladder cyst. Computed tomography revealed mesenteric, retroperitoneal and inguinal lymph node swelling. The laboratory diagnostics produced the diagnosis of syphilis. The patient was successfully treated with ceftriaxone and benzylpenicillin benzathine.


Subject(s)
Hematuria/diagnosis , Lymphatic Diseases/diagnosis , Splenomegaly/diagnosis , Syphilis/drug therapy , Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Hematuria/drug therapy , Hematuria/etiology , Humans , Lymphatic Diseases/drug therapy , Lymphatic Diseases/etiology , Male , Penicillin G Benzathine/therapeutic use , Splenomegaly/drug therapy , Splenomegaly/etiology , Syphilis/complications , Syphilis/diagnosis , Treatment Outcome , Young Adult
3.
Eur J Clin Microbiol Infect Dis ; 29(12): 1571-3, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20632051

ABSTRACT

Worldwide increasing rates of Clostridium difficile infections (CDI) with severe courses and outbreaks have been reported. This change in CDI epidemiology has on one hand been related to the spread of specific PCR ribotypes (e.g. 027) and on the other hand to increased prevalence of resistant C. difficile strains. This single-centre retrospective analysis characterized resistance against erythromycin and moxifloxacin, presence of binary toxin gene and ribotypes in 73 C. difficile isolates from 2008 in comparison with 23 isolates from 1990. In 1990, five different PCR ribotypes including 027 were identified. Resistance against erythromycin was detected in 3 of 23 (13%), while 20 of 23 (87%) from all isolates were susceptible to both erythromycin and moxifloxacin. In contrast, in 2008 a significantly increased prevalence of resistant C. difficile strains was observed, with 40 of 73 (54.8%) isolates being resistant against both antibiotics. Resistant C. difficile strains were mainly assigned to PCR ribotype 001. No isolates belonging to PCR ribotype 027 were identified. Our data provide evidence that the increase of resistant C. difficile strains belonging to PCR ribotype 001 rather than the spread of C. difficile PCR ribotype 027 contribute to the changing epidemiology of CDI.


Subject(s)
Anti-Bacterial Agents/pharmacology , Aza Compounds/pharmacology , Clostridioides difficile/drug effects , Drug Resistance, Bacterial , Enterocolitis, Pseudomembranous/epidemiology , Erythromycin/pharmacology , Quinolines/pharmacology , Ribotyping , Bacterial Proteins/genetics , Bacterial Typing Techniques , Clostridioides difficile/classification , Clostridioides difficile/genetics , Cross Infection , Enterocolitis, Pseudomembranous/microbiology , Fluoroquinolones , Germany , Hospitals, University , Humans , Microbial Sensitivity Tests , Moxifloxacin , Polymerase Chain Reaction , Prevalence
4.
Gen Physiol Biophys ; 27(2): 127-42, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18645228

ABSTRACT

S100A1 is a Ca(2+)-binding protein and predominantly expressed in the heart. We have generated a mouse line of S100A1 deficiency by gene trap mutagenesis to investigate the impact of S100A1 ablation on heart function. Electrocardiogram recordings revealed that after beta-adrenergic stimulation S100A1-deficient mice had prolonged QT, QTc and ST intervals and intraventricular conduction disturbances reminiscent of 2 : 1 bundle branch block. In order to identify genes affected by the loss of S100A1, we profiled the mutant and wild type cardiac transcriptomes by gene array analysis. The expression of several genes functioning to the electrical activity of the heart were found to be significantly altered. Although the default prediction would be that mRNA and protein levels are highly correlated, comprehensive immunoblot analyses of salient up- or down-regulated candidate genes of any cellular network revealed no significant changes on protein level. Taken together, we found that S100A1 deficiency results in cardiac repolarization delay and alternating ventricular conduction defects in response to sympathetic activation accompanied by a significantly different transcriptional regulation.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Heart/physiology , S100 Proteins/physiology , Adrenergic alpha-Agonists/pharmacology , Animals , Dobutamine/pharmacology , Electrocardiography , Gene Expression Profiling , Heart Conduction System/drug effects , Isoproterenol/pharmacology , Mice , Mice, Knockout , Myocardium/metabolism , Norepinephrine/pharmacology , Oligonucleotide Array Sequence Analysis , S100 Proteins/genetics , Ventricular Function, Left/drug effects , Ventricular Pressure/drug effects
5.
Health promot. int ; 23(1): 86-97, Mar. 2008. ilus, tab
Article in English | CidSaúde - Healthy cities | ID: cid-59696

ABSTRACT

This paper describes the Model for Outcome Classification in Health Promotion and Prevention adopted by Health Promotion Switzerland (SMOC, Swiss Model for Outcome Classification) and the process of its development. The context and method of model development, and the aim and objectives of the model are outlined. Preliminary experience with application of the model in evaluation planning and situation analysis is reported. On the basis of an extensive literature search, the model is situated within the wider international context of similar efforts to meet the challenge of developing tools to assess systematically the activities of health promotion and prevention. (AU)


Subject(s)
Humans , Models, Organizational , Health Promotion/organization & administration , Primary Prevention/organization & administration , Outcome Assessment, Health Care/organization & administration , Health Behavior , Switzerland
7.
Infection ; 35(5): 356-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17721737

ABSTRACT

BACKGROUND: Nosocomial diarrhea causes prolonged hospital stay leading to additional diagnostic and therapeutic procedures resulting in higher costs. A total of 20%-25% of antibiotic-associated diarrhea (AAD) cases are attributed to Clostridium difficile. Other microorganisms like Clostridium perfringens and Staphylococcus aureus are discussed to be associated with AAD. PATIENTS AND METHODS: This study evaluated the prevalence of enterotoxigenic S. aureus in stool samples submitted to the laboratory with the diagnosis nosocomial diarrhea. A total of 2,727 stools from clinical patients were investigated for S. aureus and C. difficile. Samples were cultured for both bacteria and a C. difficile toxin A and B assay was performed from all stools. Isolated S. aureus were investigated for enterotoxin production and for resistance against methicillin. In addition, both assays were evaluated for determination of S. aureus enterotoxins directly in stool samples. RESULTS: Out of 2,727 stools investigated, 198 grew S. aureus and 148 C. difficile. Toxins A/B from C. difficile were detected in 184 stools. A total of 114 S. aureus strains produced the following enterotoxins in vitro: A, 36; B, 20; C, 19; D, 68; E, 2. Both pathogens were found in 25 stools. Twenty-nine (14.6%) S. aureus strains were identified as methicillin-resistant. The two toxin assays evaluated in this study were not able to detect S. aureus enterotoxins directly in stools. CONCLUSION: The role of enterotoxigenic S. aureus in the pathogenesis of nosocomial and AAD needs further consideration. It might be necessary to investigate stool samples from patients with AAD/nosocomial diarrhea for S. aureus on a routine basis.


Subject(s)
Cross Infection/microbiology , Diarrhea/microbiology , Enterotoxins/biosynthesis , Feces/microbiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/metabolism , Bacterial Proteins/biosynthesis , Bacterial Toxins/analysis , Clostridioides difficile/isolation & purification , Clostridioides difficile/metabolism , Cross Infection/epidemiology , Enterotoxins/analysis , Feces/chemistry , Humans , Methicillin Resistance , Microbial Sensitivity Tests , Prevalence , Staphylococcal Infections/epidemiology , Staphylococcus aureus/isolation & purification
8.
Subcell Biochem ; 45: 93-138, 2007.
Article in English | MEDLINE | ID: mdl-18193636

ABSTRACT

The S100 proteins are exclusively expressed in vertebrates and are the largest subgroup within the superfamily of EF-hand Ca2(+)-binding proteins Generally, S100 proteins are organized as tight homodimers (some as heterodimers). Each subunit is composed of a C-terminal, 'canonical' EF-hand, common to all EF-hand proteins, and a N-terminal, 'pseudo' EF-hand, characteristic of S100 proteins. Upon Ca2(+)-binding, the C-terminal EF-hand undergoes a large conformational change resulting in the exposure of a hydrophobic surface responsible for target binding A unique feature of this protein family is that some members are secreted from cells upon stimulation, exerting cytokine- and chemokine-like extracellular activities via the Receptor for Advanced Glycation Endproducts, RAGE. Recently, larger assemblies of some S100 proteins (hexamers, tetramers, octamers) have been also observed and are suggested to be the active extracellular species required for receptor binding and activation through receptor multimerization Most S100 genes are located in a gene cluster on human chromosome 1q21, a region frequently rearranged in human cancer The functional diversification of S100 proteins is achieved by their specific cell- and tissue-expression patterns, structural variations, different metal ion binding properties (Ca2+, Zn2+ and Cu2+) as well as their ability to form homo-, hetero- and oligomeric assemblies Here, we review the most recent developments focussing on the biological functions of the S100 proteins and we discuss the presently available S100-specific mouse models and their possible use as human disease models In addition, the S100-RAGE interaction and the activation of various cellular pathways will be discussed. Finally, the close association of S100 proteins with cardiomyopathy, cancer, inflammation and brain diseases is summarized as well as their use in diagnosis and their potential as drug targets to improve therapies in the future.


Subject(s)
Receptors, Immunologic/physiology , S100 Proteins/physiology , Animals , Annexin A2/physiology , Calcium-Binding Proteins/physiology , Calgranulin A/physiology , Calgranulin B/physiology , Cell Cycle Proteins/physiology , Chemotactic Factors/physiology , EF Hand Motifs , Humans , Receptor for Advanced Glycation End Products , S100 Calcium Binding Protein A6 , S100 Calcium Binding Protein A7 , S100 Calcium-Binding Protein A4 , S100 Proteins/chemistry
9.
Mol Cell Probes ; 18(4): 271-4, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15271388

ABSTRACT

Toxigenic Clostridium difficile isolates harbor a 19 kb pathogenicity locus that encodes the genes for toxins A and B. Toxins A and B are among the largest known bacterial toxins expressing potent cytotoxicity and enterotoxicity, and thus the major virulence factors in C. difficile associated diarrhea. Cloning and sequencing of toxin genes is of interest for studies of molecular pathogenesis. We report the amplification and cloning of the complete toxin A gene into an Escherichia coli expression vector. Ten clones analyzed contained the complete toxin A gene. Four of these clones showed cytotoxic activity in cell culture, and were positive for toxin A as determined by ELISA. Toxin A expression was confirmed by Western immunoblot analysis. The presence of cytotoxic activity in cell culture suggests that toxin A activity is independent of other genes in the pathogenicity locus.


Subject(s)
Bacterial Toxins/genetics , Clostridioides difficile/genetics , Enterotoxins/genetics , Escherichia coli/genetics , Blotting, Western , Cloning, Molecular , Enzyme-Linked Immunosorbent Assay , Polymerase Chain Reaction
10.
Arch Dermatol Res ; 295(12): 535-41, 2004 May.
Article in English | MEDLINE | ID: mdl-15034722

ABSTRACT

The subcellular localization, efficacy and photooxidative mechanism of three new photosensitizing porphycenes (HexoTMPn, PeloTMPn, CpoTMPn) for photodynamic therapy with different substituents at position 9 of the tetrapyrrole macrocycle were investigated in vitro using different human skin-derived cell lines (HaCaT, SCL I, SCL II) with the aim of customizing the side-chain chemistry to accelerate cellular uptake and so enhance photodynamic activity. Cells were incubated with a porphycene and costained with organelle-specific markers. Subcellular localization was determined by fluorescence microscopy. Also, cells were incubated with different sensitizer concentrations (0-1000 nmol/l) and irradiated by an incoherent light source (lambda(em) = 600-750 nm, 40 mW/cm(2), 24 J/cm(2)) with/without quenchers or enhancers (NaN(3), histidine, mannitol or D(2)O). Cell viability was assessed. All porphycenes were localized in perinuclear lysosomes and induced a decrease in mitochondrial activity following irradiation. HexoTMPn was the most efficient in all three cell lines (EC(50) in HaCaT cells: HexoTMPn 14 nmol/l, CpoTMPn 62 nmol/l, PeloTMPn 89 nmol/l). Addition of either NaN(3) or histidine reduced the phototoxicity significantly. Due to the short lifetime of singlet oxygen, the sites of sensitizer localization are the initial subcellular targets. The cytotoxicity of each sensitizer varied depending on singlet oxygen quantum yield and cell line. Despite the different chemical structures, the biological effects were not very distinct, since they seemed to be mostly determined by the tetrapyrrole ring and only slightly modified by the substituent at position 9. Also, there was only a narrow margin between biological compatibility and efficacy.


Subject(s)
Photosensitizing Agents/pharmacology , Porphyrins/pharmacology , Cell Line , Cell Survival/drug effects , Humans , Structure-Activity Relationship
11.
Clin Microbiol Infect ; 9(6): 526-30, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12848728

ABSTRACT

OBJECTIVE: Moxifloxacin is characterized by high activity against Gram-positive cocci and some Gram-positive and -negative anaerobes, including Clostridium difficile. This study investigates the role of prior quinolone use in relation to patterns of susceptibility of C. difficile to moxifloxacin. METHODS: Sixty-three clinical isolates of C. difficile were investigated for toxigenicity, susceptibility to moxifloxacin, and mutations in the DNA gyrase gene. The medical histories for 50 of these patients were available and used to identify previous fluoroquinolone use. RESULTS: Thirty-three (52.4%) strains showed resistance to moxifloxacin (MICs > or = 16 mg/L). All moxifloxacin-resistant strains harbored a mutation at amino acid codon Ser-83 of gyrA. Forty-five isolates (71.4%) were toxigenic; all moxifloxacin-resistant strains were in this group. Resistance to moxifloxacin was associated with prior use of fluoroquinolones (P-value 0.009, chi-square). CONCLUSIONS: Although the use of moxifloxacin to treat C. difficile-associated diarrhea is not likely to be common, these data show a relationship between antecedent fluoroquinolone use and resistance to moxifloxacin in C. difficile isolates, and raise questions regarding selection pressure for resistance placed on colonizing bacteria exposed to fluoroquinolones. Mutations in gyrA are involved in moxifloxacin resistance.


Subject(s)
Anti-Infective Agents/pharmacology , Aza Compounds , Clostridioides difficile/drug effects , Drug Resistance, Bacterial/physiology , Fluoroquinolones/pharmacology , Quinolines , Clostridioides difficile/genetics , Drug Resistance, Bacterial/genetics , Enterocolitis, Pseudomembranous/drug therapy , Fluoroquinolones/adverse effects , Humans , Moxifloxacin , Polymerase Chain Reaction
12.
Eur J Med Res ; 7(10): 447-52, 2002 Oct 29.
Article in English | MEDLINE | ID: mdl-12435623

ABSTRACT

Porphyromonas gingivalis (PG) is a micro-organism that is suggested to play an etiologic role in acute and chronic periodontitis. The present study was undertaken to evaluate the question whether PG is capable of inducing interleukin (IL)-1beta, IL-6, macrophage inflammatory protein (MIP)-2, and granulocyte-macrophage colony-stimulating factor (GM-CSF) production in macrophages. Furthermore, the effect of PG on the activation of macrophages by Escherichia coli-lipopolysaccharide (LPS) was studied. The cytokines were analyzed by detection of specific mRNA. The mRNA was amplified by RT-PCR and semi-quantitatively analyzed by high performance liquid chromatography and densitometrically, respectively. These studies demonstrate that LPS was more active than PG in inducing mRNA expression of IL-1beta, IL-6, MIP-2 and GM-CSF. Moreover, PG reduced the mRNA expression of the macrophages stimulated with LPS, especially the IL-1beta and IL-6 mRNA expression was decreased.


Subject(s)
Lipopolysaccharides/pharmacology , Macrophage Activation/physiology , Porphyromonas gingivalis/pathogenicity , Animals , Cell Line , Chromatography, High Pressure Liquid , Macrophage Activation/drug effects , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
13.
Mol Cell Probes ; 16(3): 179-83, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12144768

ABSTRACT

The toxin genes of Clostridium difficile have been previously cloned by reconstructing the entire gene in a series of steps in sequence using several cloned fragments. Amplification of a 7.9 kb fragment corresponding to the toxin B gene (tcdB) was obtained with EXPAND Long Template PCR system. The amplified fragment was inserted into the E. coli expression vector pBAD and cloned into competent E. coli TOP 10 cells. tcdB gene sequences representing the complete toxin gene were detected in 3/120 (2.5%) clones analyzed. Culture filtrates of 2/3 clones were found to have cytotoxic activity in human lung fibroblasts. The recombinant protein expressed in E. coli was identified as toxin B by Western immunoblot analysis using C. sordellii antitoxin. This rapid cloning method may be useful in determining the role that individual genes in the pathogenicity locus (PaLoc) play in the virulence of C. difficile. Our results also suggest that the activity of toxin B is independent of other genes in the PaLoc.


Subject(s)
Bacterial Proteins , Bacterial Toxins/genetics , Cloning, Molecular/methods , Bacterial Toxins/biosynthesis , Bacterial Toxins/pharmacology , Cell Death/drug effects , Clostridioides difficile/genetics , Clostridioides difficile/pathogenicity , Escherichia coli/genetics , Fibroblasts/drug effects , Humans , Lung/cytology , Polymerase Chain Reaction , Virulence/genetics
14.
Lasers Med Sci ; 17(2): 70-8, 2002.
Article in English | MEDLINE | ID: mdl-12111589

ABSTRACT

For several years the flashlamp-pumped pulsed dye laser (FPDL) has been the favoured method for the treatment of port-wine stains (PWS). The therapeutic outcome of FPDL laser therapy depends on the anatomical location of the PWS and is mainly attributed to morphological parameters such as size and depth of the PWS blood vessels. The aim of this study was to show a correlation between the therapeutic outcome following FPDL therapy and the optical properties of the skin overlying the PWS vessels. For this purpose the therapeutic outcome following FPDL treatment (585 nm; 0.45 ms) of 884 PWS situated on different body sites was evaluated by judging the grade of fading of PWS colour. On the other hand the light penetration into 123 skin samples (thickness 0.10-1.35 mm) was determined between 450 nm and 1030 nm and compared with the PWS laser therapy outcome for equal locations by statistical analysis. PWS on the neck, trunk, arms or legs yielded a higher mean grade of fading as compared to PWS on the head. Within the face, a wide range of fading was evident. The light penetration into skin increased linearly with increasing wavelength and location-dependent differences were found. The attenuation coefficient was 22.8+/-5.3 mm(-1) at 585 nm. No significant or strong correlation was observed between the therapeutic outcome of PWS laser therapy and the light penetration into skin. However, a correlation was obvious by plotting the respective profile plots. Therefore, among other effects, in particular morphological parameters of PWS vessels, the optical properties of the skin contribute to a small extent to the clinical outcome of PWS laser therapy.


Subject(s)
Laser Therapy , Port-Wine Stain/radiotherapy , Skin/radiation effects , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Light , Linear Models , Male , Middle Aged , Treatment Outcome
15.
Mol Cell Probes ; 15(5): 301-6, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11735302

ABSTRACT

Toxigenic Clostridium difficile is the etiologic agent of C. difficile-associated diarrhoea (CDAD), the most common cause of hospital-acquired infectious diarrhoea. The genes tcdA and tcdB, which encode for the toxin A and B proteins, are part of the pathogenicity locus (PaLoc) of toxigenic C. difficile. Genetic and virulence studies at the molecular level in C. difficile have been hindered by the lack of techniques for DNA manipulation in this species. We describe the electroporation of DNA fragments from a toxigenic isolate into a non-toxigenic strain of C. difficile. Using previously described methods of electroporation into Clostridium spp., the complete toxin B gene and polymerase chain reaction (PCR) fragments of the PaLoc were cloned and electroporated into a non-toxigenic strain of C. difficile. The resulting transformed clones were screened for the introduced gene fragments by PCR, which confirmed their presence. This is the first description of introduction of DNA into C. difficile by electroporation.


Subject(s)
Bacterial Proteins , Bacterial Toxins/genetics , Clostridioides difficile/genetics , Clostridioides difficile/pathogenicity , Clostridium Infections/etiology , Electroporation/methods , Cloning, Molecular , DNA, Bacterial/genetics , Humans , Polymerase Chain Reaction , Virulence
16.
Infection ; 29(5): 278-9, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11688907

ABSTRACT

Listeria monocytogenes accounts for 8-11% of the cases of bacterial meningitis which is associated with high mortality in patients with serious underlying diseases or those receiving immunosuppressive treatment. Brain abscess due to L. monocytogenes is a very rare occurrence. The case reported here concerns a 54-year-old female patient with a rapidly growing tumor-like brain lesion. L. monocytogenes type 4b could be cultured from blood and brain biopsy. Despite antimicrobial therapy with ampicillin and gentamicin, the patient died 11 days after admission to the hospital. The growing numbers of elderly and immunocompromised patients will increasingly confront physicians with patients with listeriosis. Delayed therapy in patients treated with corticosteroids may result in a fatal outcome.


Subject(s)
Brain Abscess/microbiology , Listeria monocytogenes/isolation & purification , Adrenal Cortex Hormones/therapeutic use , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Brain Abscess/diagnosis , Brain Abscess/pathology , Brain Neoplasms/diagnosis , Diagnosis, Differential , Disease Progression , Fatal Outcome , Female , Gentamicins/therapeutic use , Humans , Listeria monocytogenes/pathogenicity , Magnetic Resonance Imaging , Middle Aged , Penicillins/therapeutic use , Tomography, X-Ray Computed
17.
Infection ; 29(4): 205-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11545481

ABSTRACT

BACKGROUND: Stenotrophomonas maltophilia is an opportunistic microorganism, often highly resistant to routinely tested antibiotics. This microorganism is isolated in specimens from patients with nosocomial infections with increasing frequency. PATIENTS AND METHODS: During a 1-year period (1998/1999) S. maltophilia was isolated from 137 specimens (0.26% of all investigated specimens) from 80 patients who were treated in a 1,500 bed major tertiary care teaching hospital in Leipzig. The data of 76 patients (133 specimens) could be collected and analyzed completely. RESULTS: The pathogen was most frequently detected in specimens from the respiratory tract (54%). In five patients (six cases) S. maltophilia was isolated from blood cultures (0.3% of all positive blood cultures; 1.4% of all gram-negative isolates from blood cultures). 70 of the infected patients were inpatients and 32 (42%) of them were treated on the internal medicine wards. Of these 32 patients only six (19%) were pretreated with imipenem. The Length of stay at the hospital resulted in an independent increased risk of infection with S. maltophilia. In addition, this organism was detected in six infected outpatients. CONCLUSION: S. maltophilia is not only a nosocomial pathogen. Pretreatment with a carbapenem is no longer an unequivocal risk factor for an infection with S. maltophilia.


Subject(s)
Cross Infection/epidemiology , Cross Infection/microbiology , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Stenotrophomonas maltophilia/isolation & purification , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Female , Gram-Negative Bacterial Infections/drug therapy , Humans , Male , Middle Aged , Prospective Studies , Risk Factors
18.
Diagn Microbiol Infect Dis ; 40(3): 103-6, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11502376

ABSTRACT

Clostridium innocuum isolates resistant to vancomycin (MIC values of 16-24 microg/mL) were isolated from three patients with recurrent Clostridium difficile -associated diarrhea (CDAD). We discuss the clinical significance and problems associated with the identification and differentiation of these two clostridial species, which may result in misdiagnosis of patients.


Subject(s)
Clostridium/classification , Diarrhea/microbiology , Enterocolitis, Pseudomembranous/microbiology , Clostridioides difficile/classification , Clostridioides difficile/drug effects , Clostridioides difficile/genetics , Clostridium/drug effects , Clostridium/genetics , Clostridium/isolation & purification , Clostridium Infections/microbiology , Humans , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis , Recurrence
19.
Antimicrob Agents Chemother ; 45(8): 2348-53, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11451695

ABSTRACT

Clostridium difficile is the etiological agent of antibiotic-associated colitis and the most common cause of hospital-acquired infectious diarrhea. Fluoroquinolones such as ciprofloxacin are associated with lower risks of C. difficile-associated diarrhea. In this study, we have analyzed 72 C. difficile isolates obtained from patients with different clinical courses of disease, such as toxic megacolon and relapses; the hospital environment; public places; and horses. They were investigated for their susceptibilities to moxifloxacin (MXF), metronidazole (MEO), and vancomycin (VAN). Mutants highly resistant to fluoroquinolones were selected in vitro by stepwise exposure to increasing concentrations of MXF. The resulting mutants were analyzed for the presence of mutations in the quinolone resistance-determining regions of DNA gyrase (gyrA), the production of toxins A and B, and the epidemiological relationship of these isolates. These factors were also investigated using PCR-based methods. All strains tested were susceptible to MEO and VAN. Twenty-six percent of the clinical isolates (19 of 72) were highly resistant to MXF (MIC > or = 16 microg/ml). Fourteen of these 19 strains contained nucleotide changes resulting in amino acid substitutions at position 83 in the gyrA protein. Resistant strains selected in vitro did not contain mutations at that position. These findings indicate that resistance to MXF in a majority of cases may be due to amino acid substitution in the gyrA gene.


Subject(s)
Anti-Infective Agents/pharmacology , Aza Compounds , Bacterial Proteins , Clostridioides difficile/genetics , DNA Topoisomerases, Type II/genetics , DNA, Bacterial/genetics , Fluoroquinolones , Mutation , Quinolines , Bacterial Toxins/metabolism , Base Sequence , Clostridioides difficile/drug effects , Clostridioides difficile/metabolism , DNA Gyrase , DNA Primers/chemistry , Drug Resistance, Microbial , Enterotoxins/metabolism , Humans , Microbial Sensitivity Tests , Molecular Sequence Data , Moxifloxacin , Polymerase Chain Reaction , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...